drugset / Trial / NCT07825454

Pilot Study of Hydroxychloroquine for the Treatment of AIMSS

NCT07825454 ↗

Phase 2 Not yet recruiting 35 enrolled Indiana University 100 Voices of Hope · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effectiveness of hydroxychloroquine sulfate (a type of drug commonly used to treat joint pain caused by inflammation, swelling) in reducing joint pain associated with Aromatase Inhibitor Associated Musculoskeletal Syndrome (AIMSS) for patients with breast cancer.

Timeline

Start
2026-09
Primary completion
2029-12
Completion
2029-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxychloroquine Small molecule 400 mg Oral

Indications